Non-coding RNAs Involved in the Molecular Pathology of Alzheimer's Disease: a Systematic Review

Overview

Journal Front Neurosci

Date 2024 Jul 15

PMID 39005845

Authors

Reynand Jay Canoy

Jenica Clarisse Sy

Christian Deo Deguit

Caitlin Bridgette Castro

Lyoneil James Dimaapi

Beatrice Gabrielle Panlaqui

Wenzel Perian

Justine Yu

John Mark Velasco

Jesus Emmanuel Sevilleja

Anna Gibson

Affiliations

Soon will be listed here.

Abstract

Systematic Review Registration: PROSPERO, https://www.crd.york.ac.uk/prospero/, CRD42022355307.

Citing Articles

Editorial: Noncoding RNAs in neurodegenerative disorders: from current insights and future directions to translational modeling and therapeutic approaches.

Li Y, Bhinge A, Inoue S, Garcia G Front Neurosci. 2024; 18:1497673.

PMID: 39534022 PMC: 11554652. DOI: 10.3389/fnins.2024.1497673.

Cognitive synaptopathy: synaptic and dendritic spine dysfunction in age-related cognitive disorders.

Barrantes F Front Aging Neurosci. 2024; 16:1476909.

PMID: 39420927 PMC: 11484076. DOI: 10.3389/fnagi.2024.1476909.

The Association between Long Non-Coding RNAs and Alzheimer's Disease.

Black C, Braden A, Nasim S, Tripathi M, Xiao J, Khan M Brain Sci. 2024; 14(8).

PMID: 39199508 PMC: 11353078. DOI: 10.3390/brainsci14080818.

References

Zhang M, Bian Z . The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease. Front Aging Neurosci. 2021; 13:691512. PMC: 8311738. DOI: 10.3389/fnagi.2021.691512. View

Komatsu S, Kitai H, Suzuki H . Network Regulation of microRNA Biogenesis and Target Interaction. Cells. 2023; 12(2). PMC: 9856966. DOI: 10.3390/cells12020306. View

Huang Z, Zhao J, Wang W, Zhou J, Zhang J . Depletion of LncRNA NEAT1 Rescues Mitochondrial Dysfunction Through NEDD4L-Dependent PINK1 Degradation in Animal Models of Alzheimer's Disease. Front Cell Neurosci. 2020; 14:28. PMC: 7043103. DOI: 10.3389/fncel.2020.00028. View

Idda M, Munk R, Abdelmohsen K, Gorospe M . Noncoding RNAs in Alzheimer's disease. Wiley Interdiscip Rev RNA. 2018; 9(2). PMC: 5847280. DOI: 10.1002/wrna.1463. View

Seath P, Macedo-Orrego L, Velayudhan L . Clinical characteristics of early-onset versus late-onset Alzheimer's disease: a systematic review and meta-analysis. Int Psychogeriatr. 2023; 36(12):1093-1109. DOI: 10.1017/S1041610223000509. View

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q . MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets. Biomed Pharmacother. 2022; 148:112681. DOI: 10.1016/j.biopha.2022.112681. View

Li J, Wang H . miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1. Biosci Rep. 2018; 38(6). PMC: 6239251. DOI: 10.1042/BSR20180051. View

Chen L, Guo X, Li Z, He Y . Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review. Pathol Res Pract. 2018; 215(1):12-20. DOI: 10.1016/j.prp.2018.11.012. View

10.

Lei X, Lei L, Zhang Z, Zhang Z, Cheng Y . Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Int J Clin Exp Pathol. 2015; 8(2):1565-74. PMC: 4396232. View

11.

Hadar A, Milanesi E, Walczak M, Puzianowska-Kuznicka M, Kuznicki J, Squassina A . SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease. Sci Rep. 2018; 8(1):8465. PMC: 5981646. DOI: 10.1038/s41598-018-26547-6. View

12.

Zhu H, Wang L, Wang M, Song B, Tan S, Teng J . MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1. Brain Res Bull. 2012; 88(6):596-601. DOI: 10.1016/j.brainresbull.2012.05.018. View

13.

Nikolac Perkovic M, Videtic Paska A, Konjevod M, Kouter K, Strac D, Nedic Erjavec G . Epigenetics of Alzheimer's Disease. Biomolecules. 2021; 11(2). PMC: 7911414. DOI: 10.3390/biom11020195. View

14.

Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt H, Bussche H . Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ. 2005; 331(7512):321-7. PMC: 1183129. DOI: 10.1136/bmj.331.7512.321. View

15.

Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodriguez I, Cadena-Suarez A, Sanchez-Garibay C . Alzheimer's Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023; 24(4). PMC: 9966419. DOI: 10.3390/ijms24043754. View

16.

Ding Y, Luan W, Shen X, Wang Z, Cao Y . LncRNA BDNF-AS as ceRNA regulates the miR-9-5p/BACE1 pathway affecting neurotoxicity in Alzheimer's disease. Arch Gerontol Geriatr. 2022; 99:104614. DOI: 10.1016/j.archger.2021.104614. View

17.

Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M . Role of RAGE in Alzheimer's Disease. Cell Mol Neurobiol. 2015; 36(4):483-95. PMC: 11482350. DOI: 10.1007/s10571-015-0233-3. View

18.

Ou Y, Zhu J, Hou X, Shen X, Xu W, Dong Q . Associations of Infectious Agents with Alzheimer's Disease: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2020; 75(1):299-309. DOI: 10.3233/JAD-191337. View

19.

Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller S, Frese K . A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013; 14(7):R78. PMC: 4053778. DOI: 10.1186/gb-2013-14-7-r78. View

20.

Asadi M, Hassani M, Kiani S, Sabaie H, Moslehian M, Kazemi M . The Perspective of Dysregulated LncRNAs in Alzheimer's Disease: A Systematic Scoping Review. Front Aging Neurosci. 2021; 13:709568. PMC: 8490871. DOI: 10.3389/fnagi.2021.709568. View